Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
DFMO + Bortezomib for Neuroblastoma
Recruiting1 awardPhase 1 & 2
Little Rock, Arkansas
This trial is testing an investigational drug (DFMO) in combination with bortezomib for relapsed and refractory neuroblastoma. It will evaluate safety, tolerability, and tumor response.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.